Vitamin Shoppe, a leading specialty retailer and direct marketer of vitamins, announced terms for its IPO on Wednesday. The North Bergen, NJ-based company plans to raise $136 million by offering 9.1 million shares at a price range of $14.00 to $16.00. At the mid-point of the proposed range, Vitamin Shoppe will command a market value of $415 million. Vitamin Shoppe, which was founded in 1977 and booked $641 million in sales over the last 12 months, plans to list on the NYSE under the symbol VSI. J.P. Morgan, BofA Merrill Lynch, and Barclays Capital are the lead underwriters on the deal. The deal is expected to price during the week of Oct. 26.
